Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 86770-74-3 | MDL No. : | MFCD01752874 |
Formula : | C8H19NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ANOJXMUSDYSKET-UHFFFAOYSA-N |
M.W : | 193.24 | Pubchem ID : | 160103 |
Synonyms : |
|
Chemical Name : | 2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethanol |
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 10 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 47.69 |
TPSA : | 73.94 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -8.79 cm/s |
Log Po/w (iLOGP) : | 2.3 |
Log Po/w (XLOGP3) : | -1.84 |
Log Po/w (WLOGP) : | -1.01 |
Log Po/w (MLOGP) : | -1.27 |
Log Po/w (SILICOS-IT) : | 0.25 |
Consensus Log Po/w : | -0.31 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | 0.78 |
Solubility : | 1170.0 mg/ml ; 6.04 mol/l |
Class : | Highly soluble |
Log S (Ali) : | 0.81 |
Solubility : | 1230.0 mg/ml ; 6.39 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -1.41 |
Solubility : | 7.54 mg/ml ; 0.039 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 2.49 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With hydrogen In methanol for 12 h; | The azide was combined with Pd/C (150 mg) in MeOH (7.0 ml_) and stirred 12 h under H2 (1 atm). The suspension was filtered over celite and the filtrate was concentrated to afford the amine (0.520 g, 2.7 mmol) in quantitative yields (Xie, H. Z.; Braha, O.; Gu, L. Q.; Cheley, S.; Bayley, H. Chem. Biol. 2005, 12, 109-120.) |
90% | With palladium 10% on activated carbon; hydrogen In dichloromethane for 24 h; | To the alcohol 11-azido-3,6,9-trioxaundecan-1-ol, 2 (1.00 g, 4.56 mmol)dissolved in 0H2012 (8 mL), catalytic amount of 10percent Palladium on carbon(Pd/C) was added, and the reaction was stirred under H2 pressure (4 atm) during 24 hours. The solution was filtered through a short pad of celite and the solvent was evaporated. The amino derivative was isolated by flash column chromatography, eluting with a mixture CH2CI2/ MeOH (9:1), to give 4(790mg, 90percent) as a yellow-coloured syrup. 1H NMR (400 MHz): 6 3.70 (t, 2H, J =4.8 Hz, HOCH2CH2), 3.65—3.60 (m, 1OH, 5CH20), 3.56 (t, 2H, J = 4.8 Hz, OCH2CH2N), 3.50 (t, 2H, J = 4.8 Hz, CH2NH2), 2.83 (5, 2H, NH2), 2.27 (5, 1 H, OH) ppm. 130 NMR (100 MHz): 673.0 (NCH2C), 70.6, 70.3, 70.2, 69.9, 61.5 (COH), 41.5 (ON) ppm. HRMS calcd. for O8H2oNO4[M+H]: 194.1398; found194.1392. |
86% | With water; triphenylphosphine In tetrahydrofuran at 20℃; for 4 h; | Example 3; This example describes the transformation of the azide product from example 2 to 2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethanol.; The azido product from example 2 (3.3 g, 15.1 mmol), triphenylphosphine (4.4 g, 16.8 mmol), and water (405 mg, 22.5 mmol) were mixed with 20-mL THF. After the solution was stirred for 4 hrs. at RT, the solvent was eliminated under reduced pressure and the residual product was purified on a silica-gel column that was eluted with CHCl3/CH3OH/Et3N (3:3:1). The desired compound was obtained as colorless oil (2.5 g, 86percent yield): Rf0.4 (CHCl3/CH3OH/Et3N, 3:3:1). Detection of the products on TLC plates was accomplished using a sulfuric acid solution (25.0 mL of conc. sulfuric acid, 12.6 g of ammonium molybdate, 0.57 g of cerium sulfate, and 225.0 mL of deionized water) and/or ninhydrin test solution (a mixture of solution i, ii, and iii: (i) 1 mL of 0.1 M aqueous potassium cyanide diluted to 50 mL with pyridine; (ii) 2.5 g of ninhydrin in 50 mL of ethanol; (iii) 40 g of phenol in 10 mL of ethanol). 1H-NMR (CDCl3) δ3.76-3.51 (m, 14H, CH2OCH2, HOCH2), 2.82 (t, J=4.9 Hz, 2H, CH2N). |
79.6% | With water; triphenylphosphine In tetrahydrofuran at 20℃; for 5 h; | [0155] In the above reaction, at RT, compound 36 (278 mg), PPh3 (366 mg), and water (34 mg), were added to 5 mL THF, and stirred for four hours. Then the solvent was removed and the residue was purified by column (CHCl3/MeOH/Et3N 3:3:1). 195 mg of product 37 was obtained as light yellow oil, in a yield of 79.6percent. |
8 g | With triphenylphosphine In tetrahydrofuran at 20℃; for 24 h; Cooling with ice | THF (50 mL) was added to N3-EG4-OH (9.2 g, 42.0 mmol). The resulting mixture was placed in an ice-water bath, and added dropwise with THF (75 mL) containing triphenylphosphine (13.21 g, 50.4 mmol, 1.2 eq). The reaction was carried out at room temperature for 24 hours. The resulting mixture was added with water (1965 uL, 109.2 mmol, 2.6 eq), and reacted at room temperature overnight. The resulting mixture was evaporated to remove the solvent, added with water (150 mL), washed with toluene (150 mL) and DCM (100 mL), and evaporated to remove the water phase to give 8 g product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | at 20℃; for 2.16667 h; | EXAMPLE 5 Synthesis of 4-(2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)ethoxy)-2-(2,6-dioxopiperidin-3- yl)isoindoline- 1 ,3-dione Step 1: Synthesis of S9 To a round-bottom flask, 2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)ethanol (2.9 g, 15 mmol) was diluted in 10 mL of ethanol. Di-tert-butyl dicarbonate (3.6 g, 16.5 mmol) was dissolved in 10 mL of ethanol and the solution was dropwised within a period of 10 min. The resulting reaction mixture was stirred at room temperature for 2 h. After evaporation of the solvent, the residue was purified by column chromatography with DCM/ MeOH to obtain S9 as colorless oil (3.69 g, 80percent yield). 1H NMR (400 MHz, CDCI3) δ (ppm) 5.49 (s, 1H), 3.46-3.25 (m, 14H), 3.02 (s, 2H), 1.18 (s, 9H); ESI-MS calculated for Ci3H27NNa06 [M+Na]+ = 316.17, obtained: 316.18. |
44% | With sodium hydroxide In tetrahydrofuran; water at 20℃; for 16 h; | Into a 100-mL round-bottom flask, was placed a solution of 2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethan-1-ol (3.0 g, 15.52 mmol, 1.00 equiv) in tetrahydrofuran/water (30/30 mL), di-tert-butyl dicarbonate (3.6 g, 16.49 mmol, 1.05 equiv), sodium hydroxide (2.5 g, 62.50 mmol, 4.00 equiv). The resulting solution was stirred for 16 h at room temperature. The resulting solution was diluted with water (20 mL) and extracted with ethyl acetate (20 mL*3). The combined organic layers were washed with brine (20 mL*1), dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column and eluted with ethyl acetate/petroleum ether (1:1). This resulted in 2.0 g (44percent) of tert-butyl N-(2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl)carbamate as light yellow oil. LC-MS (ES+): m/z 294.05 [MH+], tR=0.93 min, (1.9 minute run). |
15% | at 20℃; for 18 h; | To a stirred solution of 87 2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)ethanol (100μL, 0.55mmol) in 88 dioxane (1mL) was added Boc2O (152μL, 0.66mmol). The mixture was stirred for 18hat rt and then evaporated under reduced pressure. The crude was taken up in DCM (6mL), washed with H2O (2×6mL) and brine (1×5mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified using flash silica column chromatography (99:1 DCM:MeOH) to yield the desired 89 tert-butyl N-(2-{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}ethyl)carbamate (24mg, 81.8μmol, 15percent), as a pale yellow oil (Rf 0.52, 9:1 DCM:MeOH). 1H NMR (400MHz, CDCl3) δ 3.75–3.67 (m, 4H, O-CH2), 3.66–3.57 (m, 8H, O-CH2CH2-O), 3.52 (t, J=5.2Hz, 2H, O-CH2), 3.29 (t, J=5.2Hz, 2H, NH-CH2), 1.43 (s, 9H, CH3 t Bu). 13C NMR (101MHz, CDCl3) δ 156.31, 79.19, 72.77, 70.72, 70.67, 70.55, 70.36, 70.20, 61.76, 40.67, 28.56. HRMS-ESI calculated for C13H27NNaO6 [M+Na]+ 316.1731, found m/z 316.1738. A solution of 91 bromine (7.3μL, 0.14mmol) in 67 DCM (0.2mL) at 0°C was added to a solution of 92 triphenylphosphine (37mg, 0.14mmol) and 93 Et3N (20μL, 0.14mmol) in anhydrous DCM (0.2mL) at 0°C. Following stirring at 0°C for 30min, a solution of 89 tert-butyl N-(2-{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}ethyl)carbamate (42mg, 0.14mmol) in DCM (0.2mL) was added dropwise. After stirring at 0°C for 2h, the mixture was evaporated under reduced pressure. The crude product was purified using flash silica column chromatography (5:1 hexane:EA) to yield the desired 94 tert-butyl N-(2-{2-[2-(2-bromoethoxy)ethoxy]ethoxy}ethyl)carbamate (13mg, 36.5μmol, 26percent) as a colourless oil. 1H NMR (400MHz, CDCl3) δ 5.03 (br s, 1H, NH), 3.81 (t, J=6.3Hz, 2H, O-CH2), 3.73–3.58 (m, 8H, O-CH2CH2-O), 3.54 (t, J=5.1Hz, 2H, O-CH2), 3.47 (tJ=6.3, 1.2Hz, 2H, CH2Br), 3.31 (q, J=5.6Hz, 2H, NH-CH2), 1.44 (s, 9H, CH3 t Bu). HRMS-ESI calculated for C13H26BrNNaO5 [M+Na]+ 378.0887, found m/z 378.0894. To a solution of 9e (13mg, 35.1μmol) in anhydrous DMF (0.7mL) was added NaH (60percent by mass dispersion in mineral oil) (5.5mg, 0.14mmol). After stirring for 30min, a solution of tert-butyl N-(2-{2-[2-(2-bromoethoxy)ethoxy]ethoxy}ethyl)carbamate (12.5mg, 35.1μmol) in anhydrous DMF (0.6mL) was added. The reaction mixture was stirred for 18h, then quenched with H2O (1.5mL), extracted with EA (4×2mL), washed with H2O (2×7mL), dried over MgSO4, filtered and evaporated under reduced pressure. The crude product was purified using flash silica column chromatography (99:1 DCM:MeOH) and semi-preparative RP-HPLC to yield the desired 17 (6.88mg, 10.7μmol, 31percent), as a white solid. 1H NMR (400MHz, DMSO-d6) δ 7.97 (s, 1H, ArH indole), 7.81–7.75 (m, 3H, ArH indole and MeOPh), 7.58 (d, J=9.0Hz, 1H, ArH indole), 7.12–7.05 (m, 2H, ArH MeOPh), 6.95 (dd, J=8.9, 2.5Hz, 1H, ArH indole), 6.74 (br s, 1H, NH), 4.21–4.07 (m, 4H, N1-CH2 & indole-O-CH2), 3.86 (s, 3H, O-CH3), 3.85–3.75 (m, 4H, O-CH2 & O-CH2 THP), 3.65–3.45 (m, 8H, O-CH2CH2-O), 3.37 (t, J=6.1Hz, 2H, O-CH2), 3.19 (td, J=11.7, 2.0Hz, 2H, O-CH2 THP), 3.05 (q, J=6.0Hz, 2H, NH-CH2), 2.13–2.02 (m, 1H, CH THP), 1.41–1.21 (m, 13H, O-CH2CH2 THP, CH3 t Bu). HRMS-ESI calculated for C35H48N2NaO9 [M+Na]+ 663.3252, found m/z 663.3247. Analytical RP-HPLC Rt=21.00min. |
[ 60792-79-2 ]
2,2'-Oxybis(ethylamine) dihydrochloride
Similarity: 0.87
[ 944561-44-8 ]
2-[2-(2-Propynyloxy)ethoxy]ethylamine
Similarity: 0.78
[ 70384-51-9 ]
Tris(2-(2-methoxyethoxy)ethyl)amine
Similarity: 0.70
[ 60792-79-2 ]
2,2'-Oxybis(ethylamine) dihydrochloride
Similarity: 0.87
[ 944561-44-8 ]
2-[2-(2-Propynyloxy)ethoxy]ethylamine
Similarity: 0.78
[ 70384-51-9 ]
Tris(2-(2-methoxyethoxy)ethyl)amine
Similarity: 0.70
[ 112-27-6 ]
2,2'-(Ethane-1,2-diylbis(oxy))diethanol
Similarity: 0.64
[ 2615-15-8 ]
3,6,9,12,15-Pentaoxaheptadecane-1,17-diol
Similarity: 0.64
[ 23783-42-8 ]
2,5,8,11-Tetraoxatridecan-13-ol
Similarity: 0.64
[ 5617-32-3 ]
3,6,9,12,15,18-Hexaoxaicosane-1,20-diol
Similarity: 0.64
[ 60792-79-2 ]
2,2'-Oxybis(ethylamine) dihydrochloride
Similarity: 0.87
[ 944561-44-8 ]
2-[2-(2-Propynyloxy)ethoxy]ethylamine
Similarity: 0.78
[ 70384-51-9 ]
Tris(2-(2-methoxyethoxy)ethyl)amine
Similarity: 0.70